ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.485
      -0.16%
      Bitcoin
      93,423.36
      -1.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Banco De Sabadell SA (PK) (BNDSY) Quote

      Banco De Sabadell SA (PK)

      Banco De Sabadell SA (PK) (BNDSY)

      USOTC
      3.85
      0.00
      (0.00%)
      Closed January 13 4:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.85
      Bid
      3.81
      Ask
      4.22
      Volume
      11
      0.00 Day's Range 0.00
      2.35 52 Week Range 4.60
      Market Cap
      10.472B
      Previous Close
      3.85
      Open
      -
      Last Trade
      6
      @
      4.035
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      949
      Shares Outstanding
      2,720,110,724
      Dividend Yield
      5.23%
      PE Ratio
      4.37
      Earnings Per Share (EPS)
      0.49
      Revenue
      6.28B
      Net Profit
      1.33B

      About Banco De Sabadell SA (PK)

      Sector
      Commercial Banks, Nec
      Industry
      Commercial Banks, Nec
      Website
      www.bancsabadell.com
      Headquarters
      Alicante, Valencian Community, Esp
      Founded
      -
      Banco De Sabadell SA (PK) is listed in the Commercial Banks sector of the OTCMarkets with ticker BNDSY. The last closing price for Banco De Sabadell (PK) was $3.85. Over the last year, Banco De Sabadell (PK) shares have traded in a share price range of $ 2.35 to $ 4.60.

      Banco De Sabadell (PK) currently has 2,720,110,724 shares outstanding. The market capitalization of Banco De Sabadell (PK) is $10.47 billion. Banco De Sabadell (PK) has a price to earnings ratio (PE ratio) of 4.37.

      Ask ADVFN Intelligence (AI)

      BNDSY Latest News

      More News

      Scheduled Ex-Dividend

      Thu, Sep 26, 2013 08:00 - Banco De Sabadell SA (BNDSY: OTC Pink Current) - Scheduled Ex-Dividend - Banco De Sabadell SA has announced a dividend ex-date for (BNDSY: OTC Pink Current). Banco De...

      September 26 2013
      OTC Markets

      Scheduled Ex-Dividend

      Tue, Sep 24, 2013 08:00 - Banco De Sabadell SA (BNDSY: OTC Pink Current) - Scheduled Ex-Dividend - Banco De Sabadell SA has announced a dividend ex-date for (BNDSY: OTC Pink Current). Banco De...

      September 24 2013
      OTC Markets

      Splits

      Thu, Apr 04, 2013 12:00 - Banco De Sabadell SA (BNDSY: OTC Link) - Splits - Effective Thu, Apr 04, 2013, BNDSY: OTC Link engaged in a fwd split. As a result of the split, shs increased by 1.01294...

      April 04 2013
      OTC Markets

      Scheduled Ex-Dividend

      Thu, Mar 28, 2013 08:00 - Banco De Sabadell SA (BNDSY: OTC Link) - Scheduled Ex-Dividend - Banco De Sabadell SA has announced a dividend ex-date for (BNDSY: OTC Link). Banco De Sabadell SA is...

      March 28 2013
      OTC Markets
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40.010.2604166666673.843.853.83517103.83947499DR
      120.082.122015915123.773.9553.659493.80568787DR
      26-0.2-4.938271604944.054.63.3521674.01938502DR
      521.3855.87044534412.474.62.3537033.84541877DR
      1562.4165.5172413791.454.61.2440092.74456067DR
      2601.779.06976744192.154.60.53168451.38322591DR

      BNDSY - Frequently Asked Questions (FAQ)

      What is the current Banco De Sabadell (PK) share price?
      The current share price of Banco De Sabadell (PK) is $ 3.85
      How many Banco De Sabadell (PK) shares are in issue?
      Banco De Sabadell (PK) has 2,720,110,724 shares in issue
      What is the market cap of Banco De Sabadell (PK)?
      The market capitalisation of Banco De Sabadell (PK) is USD 10.47B
      What is the 1 year trading range for Banco De Sabadell (PK) share price?
      Banco De Sabadell (PK) has traded in the range of $ 2.35 to $ 4.60 during the past year
      What is the PE ratio of Banco De Sabadell (PK)?
      The price to earnings ratio of Banco De Sabadell (PK) is 4.37
      What is the cash to sales ratio of Banco De Sabadell (PK)?
      The cash to sales ratio of Banco De Sabadell (PK) is 0.93
      What is the reporting currency for Banco De Sabadell (PK)?
      Banco De Sabadell (PK) reports financial results in EUR
      What is the latest annual turnover for Banco De Sabadell (PK)?
      The latest annual turnover of Banco De Sabadell (PK) is EUR 6.28B
      What is the latest annual profit for Banco De Sabadell (PK)?
      The latest annual profit of Banco De Sabadell (PK) is EUR 1.33B
      What is the registered address of Banco De Sabadell (PK)?
      The registered address for Banco De Sabadell (PK) is AVENIDA OSCAR ESPLA 37, ALICANTE, VALENCIAN COMMUNITY, 03007
      What is the Banco De Sabadell (PK) website address?
      The website address for Banco De Sabadell (PK) is www.bancsabadell.com
      Which industry sector does Banco De Sabadell (PK) operate in?
      Banco De Sabadell (PK) operates in the COMMERCIAL BANKS, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CRGPCalissio Resources Group Inc (CE)
      $ 0.0004
      (39,900.00%)
      		20k
      SMMESmartMetric Inc (PK)
      $ 0.0001
      (9,900.00%)
      		1.25M
      NEOMNeoMedia Technologies Inc (CE)
      $ 0.0001
      (9,900.00%)
      		534.97k
      RRGIReality Racing Inc (CE)
      $ 0.0001
      (9,900.00%)
      		209k
      ELIQQElectriq Power Holdings Inc (CE)
      $ 0.0001
      (9,900.00%)
      		290
      IBKKFImining Technologies Inc (CE)
      $ 0.000001
      (-100.00%)
      		100
      EGIOQEdgio Inc (CE)
      $ 0.000001
      (-99.99%)
      		905
      CYBFCyberfort Software Inc (CE)
      $ 0.000001
      (-99.88%)
      		20k
      CHMJDWaverunner Capital Inc
       0.0045
      (-99.40%)
      		106
      CCTLCoin Citadel (PK)
      $ 0.000001
      (-99.00%)
      		108k
      HMBLHUMBL Inc (PK)
      $ 0.0009
      (0.00%)
      		359.72M
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.00015
      (50.00%)
      		194.9M
      AITXArtificial Intelligence Technology Solutions Inc (PK)
      $ 0.00375
      (-1.32%)
      		188.36M
      TSOITherapeutic Solutions International Inc (PK)
      $ 0.0002
      (-33.33%)
      		168.26M
      PHILPHI Group Inc (PK)
      $ 0.00025
      (-16.67%)
      		129.87M

      Discussion

      View Full Feed
      sunspotter sunspotter 8 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 19 minutes ago
      Marc loved your ides
      tinojax tinojax 20 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 22 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 38 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 38 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 39 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 40 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 47 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 50 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 56 minutes ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 56 minutes ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 60 minutes ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI
      Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
      Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

      And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
      KBLB
      rx7171 rx7171 2 hours ago
      Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

      To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
      AVXL

      Your Recent History

      USOTC
      BNDSY
      Banco De Sabadell (PK)
      LSE
      0Y9J
      Ubs Etfs Plc - Msci Acwi...
      LSE
      71DP
      Anz Bank 24
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads